Onocotype DX cancer testing

Ended Awarded Last action

Contract number
FA486122F0068
Awardee
Awarding agency
Obligated
$141,859

Award facts

Contract value 100% obligated
$141,858.59 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
621511 Medical Laboratories
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Las Vegas, NV 89101, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 · 99 MDG - oncotype DX cancer testing - base year oars $17,270
Original award $124,589

About this award

Genomic Health, Inc., a subsidiary of Exact Sciences Corp, has been awarded a $141,858.59 firm fixed price delivery order contract by the Department of the Air Force Air Combat Command. The contract calls for Genomic Health to provide Oncotype DX cancer testing services to support the agency's medical programs. Performance will take place in Las Vegas, Nevada. No set-aside provisions were applied to this award. Genomic Health will leverage its subsidiary Exact Sciences Laboratories to fulfill testing at the specified place of performance by the March 2023 completion date.

Quick answers

Who was awarded contract FA486122F0068?

FA486122F0068 was awarded to Genomic Health, Inc. by Air Combat Command (Air Force) on March 11, 2022.

How much is contract FA486122F0068 worth?

The government has obligated $141,859 on FA486122F0068.

Is contract FA486122F0068 an order under another contract?

Yes. FA486122F0068 is a delivery order under FA486121D0004, an indefinite delivery contract.

Was contract FA486122F0068 competed?

The extent of competition for FA486122F0068 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award